< Back to latest news & events

Event

Alternative Dairy Conference 2020

November 2020

Event date: 2nd December 2020

HGF is sponsoring Alt Dairy Conference 2020 on 2nd December.

Alternative Dairy Conference 2020 will focus on the new wave of future food companies transforming the dairy business of tomorrow.

Attendees will learn about the latest business trends and best practices to transform the future of food with alternatives for dairy applications like cheese, milk and yogurt.

HGF Partner Kerry Rees will be attending the conference and speaking on “How to use Intellectual Property to attract investors”.

IP is a key asset for technology-driven companies and is used to attract funding from investors at all stages of a company’s development.

Attendees

Latest updates

PRESS RELEASE - HGF secures private equity investment.

HGF secures private equity investment to propel its vision of being Europe’s IP Firm of Choice; to  attract top talent and to deliver excellence to clients. Over the past 30 …

Read article

Managing IP Rising Stars 2024

We are delighted to announce that 12 of our esteemed attorneys have been listed in the 2024 Managing Intellectual Property (MIP) Rising Stars guide! This prestigious recognition highlights the best …

Read article
Event - 15th - 16th October 2024

LSPN North America Fall 2024

HGF are proud to be platinum sponsors of LSPN North America Fall 2024. This year’s event will be held in San Francisco on Tuesday 15th and Wednesday 16th of October …

Event details

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article

The Patent Lawyer: UPC’s first year: emergence of a purely civil law system?

The UPC passed its milestone 1 year anniversary on 1 June 2024. At the time of writing we are still awaiting the first substantive decisions on invalidity and infringement, there …

Read article

NK Cell Therapy – an IP update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medicine’s Agency approved the first …

Read article